Recognition and Use of a Standard for Uniform Blood and Blood Component Container Labels
We, FDA, Center for Biologics Evaluation and Research (CBER), are recognizing as acceptable for use by you, manufacturers of blood and blood components, subject to United States statutes and regulations, the document entitled “United States Industry Consensus Standard for the Uniform Labeling
United States Guidance Issuing Office Drug Administration Docket Number Biologics Evaluation States Industry Consensus Standard
Source: fda.gov